Czechia – Antivirals for systemic use – LP containing molnupiravir 2026 - pooled purchase
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
The subject of the public contract is the recurring supply of medicinal products that meet the requirements of SÚKL and contain the active substance molnupiravir